Vivianne Freitas
Overview
Explore the profile of Vivianne Freitas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Freitas V, Ghai S, Au F, Muradali D, Kulkarni S
Can Assoc Radiol J
. 2024 Dec;
76(2):302-312.
PMID: 39627928
The integration of Digital Breast Tomosynthesis (DBT) and Artificial Intelligence (AI) represents a significant advance in breast cancer screening. This combination aims to address several challenges inherent in traditional screening...
3.
Ko G, Li Q, Liu N, Amir E, Covelli A, Eskander A, et al.
Breast Cancer Res Treat
. 2024 Nov;
210(1):147-156.
PMID: 39543062
Purpose: The COVID-19 pandemic significantly impacted breast cancer (BC) surgeries. Most studies showing reduced BC surgical volumes during the pandemic are from single institutions, few have described volume changes in...
4.
Rapley M, Freitas V, Weinberg I, Baldassi B, Poladyan H, Waterston M, et al.
Front Oncol
. 2024 Oct;
14:1477862.
PMID: 39386193
[This corrects the article DOI: 10.3389/fonc.2024.1405404.].
5.
Rapley M, Freitas V, Weinberg I, Baldassi B, Poladyan H, Waterston M, et al.
Front Oncol
. 2024 Aug;
14:1405404.
PMID: 39091907
Contrast-enhanced breast magnetic resonance imaging (MRI) is currently recommended as a screening tool for high-risk women and has been advocated for women with radiologically dense breast tissue. While breast MRI...
6.
Alvarenga P, Park J, Pinto R, Parente D, Lajkosz K, Westergard S, et al.
Can Assoc Radiol J
. 2024 May;
:8465371241253254.
PMID: 38795027
To investigate the features and outcomes of breast cancer in high-risk subgroups. REB approved an observational study of women diagnosed with breast cancer from 2010 to 2019. Three radiologists, using...
7.
Baldassi B, Poladyan H, Shahi A, Maa-Hacquoil H, Rapley M, Komarov B, et al.
Front Oncol
. 2024 Apr;
14:1268991.
PMID: 38590664
Introduction: A newly developed clinical organ-targeted Positron Emission Tomography (PET) system (also known as Radialis PET) is tested with a set of standardized and custom tests previously used to evaluate...
8.
9.
Yuan P, Yan T, Sharma S, Chahley E, MacLean L, Freitas V, et al.
Eur J Radiol
. 2024 Mar;
175:111428.
PMID: 38492508
Rationale And Objectives: The purpose of this study is to investigate the variance of women authors, specifically first and senior authorship among peer-reviewed artificial intelligence-related articles with a specific focus...
10.
Goulam-Houssein S, Ye X, Fleming R, Au F, Kulkarni S, Ghai S, et al.
Eur Radiol
. 2024 Mar;
34(10):6273-6282.
PMID: 38491128
Objective: This study aims to determine whether persistent T1-weighted lesions signify a complete pathological response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy and surgery, and to evaluate their...